T790M-EGFR mutation frequency in advanced NSCLC patients on progression from a previous TKI therapy: results from a Portuguese study

Teixeira, EAraújo, AHespanhol, VParente, BBarata, F2021-10-112021-10-112021Pulmonology . Sep-Oct 2021;27(5):472-473.http://hdl.handle.net/10400.26/37675engCarcinoma do Pulmão de Células não PequenasResistencia a Medicamentos AntineoplásicosReceptor ErbB-2Carcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmErbB ReceptorsT790M-EGFR mutation frequency in advanced NSCLC patients on progression from a previous TKI therapy: results from a Portuguese studyjournal article10.1016/j.pulmoe.2021.01.007